Cargando…
Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
Autoimmune diseases, such as multiple sclerosis and type-1 diabetes, are the outcomes of a failure of immune tolerance. Immune tolerance is sustained through interplays between two inter-dependent clusters of immune activities: immune stimulation and immune regulation. The mechanisms of immune regul...
Autores principales: | Zhai, Yujia, Moosavi, Reza, Chen, Mingnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097144/ https://www.ncbi.nlm.nih.gov/pubmed/33968036 http://dx.doi.org/10.3389/fimmu.2021.645699 |
Ejemplares similares
-
Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018) -
Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
por: McBride, Margaret A., et al.
Publicado: (2021) -
Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
por: Zhou, Xueyin, et al.
Publicado: (2022) -
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets
por: Cortesi, Manuela, et al.
Publicado: (2022) -
Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
por: Zheng, Meijun, et al.
Publicado: (2023)